1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. PRECISION BIOSCIENCES INC
Precision Biosciences Inc
XNAS: DTIL

Precision Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for...

Read More
7.87 -0.45 (-5.41%)
122.95% Gain from 52W Low
287.8K
XNAS Volume

XNAS 17 Jul, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Durability score
Low Financial Strength
11.1 / 100
Valuation Score
Expensive Valuation
19.0 / 100
Momentum Score
Technically Moderately Bullish
67.7 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
30
1Yr Price target upside is 276%
5 analysts

12

S

10

W

5

O

0

T

SWOT Analysis

Precision Biosciences Inc Live Price Chart

Switch to TradingView
Switch to

Precision Biosciences Inc Live Price Chart

Custom


Loading Fundamental data..


Loading data..
×